Guru Ownership Trend
Guru Analysis for Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences, Inc. (RCUS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $127.6 M.
Top institutional holders include Steven Cohen and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $4.59 M net inflow during the quarter.
Recent activity highlights Ken Fisher who increased their stake by 167.4%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 85.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Arcus Biosciences, Inc. (RCUS)
Major holders include Steven Cohen ($78.16 M), Ken Fisher ($46.46 M), Paul Tudor Jones ($4.97 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 5.56 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $4.59 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited RCUS. The total reported sell value was $29.53 M.
Yes, 1 managers opened new positions in RCUS, and 2 increased their existing holdings. The total reported buy value was $34.12 M.